Functional analysis of LR11 in vascular smooth muscle cells

LR11在血管平滑肌细胞中的功能分析

基本信息

  • 批准号:
    12835002
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

LR11, a member of the LDL receptor family, is highly expressed in vascular smooth muscle cells (SMCs) of the hyperplastic intima, but not media. To further clarify the involvement of LR11 in the process of atherosclerosis, we have characterized the migration and invasion activities, of LR11-overexpressing SMCs. LR11 cDNA was transfected into the rat SMC line, A7r5. Compared to mock cells (C-1), in the presence of PDGF-BB the transfected cells (R-1 and R-2) showed 3.5-4.0-fold higher expression of LR11 protein, 1.7-1.8-fold increased migration, and 2.0-2.2-fold elevated invasion activities, respectively. The increases were essentially abolished by the addition of receptor-associated protein (RAP), anti-LR11 antibodies, or Apo E. Immunological analyzes showed that urokinase-type plasminogen activator receptor (uPAR) levels were increased in LR11-overexpressing cells. Anti-uPA and anti-uPAR antibodies reduced the migration and invasion activities of R-1 and R-2 cells to baseline levels. RAP, anti-ER11 antibodies, and apo E decreased uPAR expression in the LR11-overexpressing cells by 〜50%. Cellular catabolism of uPAR was significantly decreased in R-1 and R-2 cells compared to control. Cultured SMCs isolated from intimae of atherosclerotic rabbit aortas showed increased expression levels of LR11 and uPAR, and enhanced migration and invasion compared to SMCs from medial layers. Overexpression of LR11 induces enhanced migration and invasion activities of intimal SMCs in vitro, likely via its regulation of the uPA/uPAR system.
LR11,在血管平滑肌细胞(SMC)中表达的LDL受体的成员。 ,A7R5与模拟细胞(C-1)B相比,转染的细胞(R-1和R-2)显示了LR11蛋白的3.5-4.0倍,迁移增加了1.7-1.8倍,2.0-2.2倍通过添加与受体相关的蛋白质(RAP),抗LR11抗体或ApoE。免疫学分析可以消除升高活性抗抗体将R-1和R-1和R-1 2细胞的迁移和侵入活性降低到基线水平。与对照组相比,R-1和R-2细胞的OFAR显着降低。系统。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Miyazaki O, Kobayashi J, Fukamachi I, Miida T, Bujo H, Saito Y.: "A new sandwich enzyme immunoassay for measurement of plasma pre-betal-HDL level"J Lipid Res.. 41(12). 2083-2088 (2000)
Miyazaki O、Kobayashi J、Fukamachi I、Miida T、Bujo H、Saito Y.:“一种用于测量血浆前 β-HDL 水平的新型夹心酶免疫测定法”J Lipid Res.. 41(12)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kanaki T, Morisaki N, Bujo H, Takahashi K, Ishii I, Saito Y: "The regulatory expression of procollagen COOH-terminal proteinase enhancer in the proliferation of vascular smooth muscle cells."Biochem Biophys Res Commun. 270(3). 1049-54 (2000)
Kanaki T、Morisaki N、Bujo H、Takahashi K、Ishii I、Saito Y:“前胶原 COOH 末端蛋白酶增强剂在血管平滑肌细胞增殖中的调节表达。”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Zhu Y., et al.: "Enhanced expression of LDLR family member LR11 increases migration of smooth muscle cells in vitro"Circulation. In press. (2002)
Zhu Y.等人:“LDLR家族成员LR11的表达增强可增加平滑肌细胞的体外迁移”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hirayama S, Bujo H, Yamazaki H, Kanaki T, Takahashi K, Saito Y.: "Differential expression of LR11 during proliferation and differentiation of cultured ~neuroblastoma cells"Biochem Biophys Res Commun. 275(2). 365-562 (2000)
Hirayama S、Bujo H、Yamazaki H、Kanaki T、Takahashi K、Saito Y.:“培养的神经母细胞瘤细胞增殖和分化过程中 LR11 的差异表达”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ishii I, et al.: "Histological and functional analysis of vascular smooth muscle cells in a novel culture system with honeycomb-like structure Atherosclerosis"Atherosclerosis. 155. 377-384 (2001)
Ishii I 等人:“具有蜂窝状结构的新型培养系统中血管平滑肌细胞的组织学和功能分析”动脉粥样硬化。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BUJO Hideaki其他文献

BUJO Hideaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BUJO Hideaki', 18)}}的其他基金

Examinational significance and production mechanism of a circulating soluble receptor for the diagnosis of activated adipocytes to prevent diabetes
循环可溶性受体对诊断激活脂肪细胞预防糖尿病的检测意义和产生机制
  • 批准号:
    16H05231
  • 财政年份:
    2016
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of the pathologically-transited immature cells diagnosed by soluble LR11
可溶性LR11诊断的病理转移未成熟细胞的鉴定
  • 批准号:
    15K15198
  • 财政年份:
    2015
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular clarification of trans-differentiation to brown adipocytes through the action of soluble receptor LR11
通过可溶性受体 LR11 的作用对棕色脂肪细胞转分化的分子澄清
  • 批准号:
    24390231
  • 财政年份:
    2012
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of cellular cytoskeleton by the soluble LDL receptor family with the application for novel anti-atherosclerosis therapy
可溶性低密度脂蛋白受体家族对细胞骨架的调节及其在新型抗动脉粥样硬化治疗中的应用
  • 批准号:
    21390277
  • 财政年份:
    2009
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Amelioration of pathological phenotypes of vascular smooth muscle cells by the sLR11 regulation
sLR11调节改善血管平滑肌细胞的病理表型
  • 批准号:
    19591036
  • 财政年份:
    2007
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular analysis and clinical application of LR11 in SMCs.
SMCs中LR11的分子分析及临床应用。
  • 批准号:
    17590917
  • 财政年份:
    2005
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of the brain-specific LDL receptor family memners
脑特异性 LDL 受体家族成员的功能分析
  • 批准号:
    09671027
  • 财政年份:
    1997
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Hp感染和LR11在糖尿病大血管病变发生发展过程中的作用
  • 批准号:
    81760148
  • 批准年份:
    2017
  • 资助金额:
    32.0 万元
  • 项目类别:
    地区科学基金项目
LR11和SorCS1在糖尿病慢性并发症发生发展过程中的作用
  • 批准号:
    81360134
  • 批准年份:
    2013
  • 资助金额:
    49.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Molecular function of LR11 in lipid metabolism of malignant lymphoma
LR11在恶性淋巴瘤脂质代谢中的分子功能
  • 批准号:
    19K07467
  • 财政年份:
    2019
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The association between SORL1 and advanced bladder cancer
SORL1与晚期膀胱癌的关联
  • 批准号:
    19K23899
  • 财政年份:
    2019
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
可溶性アポEレセプター分断放出破綻による糖尿病とアルツハイマー病の病態連関の探索
通过破坏可溶性apoE受体的破坏和释放来探索糖尿病和阿尔茨海默病之间的病理关系
  • 批准号:
    18K19526
  • 财政年份:
    2018
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Establishment of examinational basis for pathological trans-differentiation of adipocytes through soluble LR11
可溶性LR11脂肪细胞病理转分化检测依据的建立
  • 批准号:
    18K07428
  • 财政年份:
    2018
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Examinational significance and production mechanism of a circulating soluble receptor for the diagnosis of activated adipocytes to prevent diabetes
循环可溶性受体对诊断激活脂肪细胞预防糖尿病的检测意义和产生机制
  • 批准号:
    16H05231
  • 财政年份:
    2016
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了